MUC5AC and cancer: Recently, an engineered bacterial mucin-selective protease fused to a cancer antigen-binding nanobody has been shown to form a conjugate selectively degrading cancer cells mucins; this promoted cell death in culture models and reduced tumor growth in mice [16].